Literature DB >> 6707221

Splenic siderosis and parenteral iron dextran in maintenance haemodialysis patients.

J A Murray, D N Slater, M A Parsons, M Fox, S Smith, M M Platts.   

Abstract

The histological features of 40 spleens surgically removed from maintenance haemodialysis patients are reported. Twenty-four of the 40 (60%) showed massive iron loading and a significant direct correlation was found between iron loading and the amount of intravenous iron dextran administered. Since parenteral iron dextran appears to be a major factor in causing iron overload in haemodialysis patients its use as a method of iron replacement in these patients would appear inappropriate.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6707221      PMCID： PMC498619          DOI： 10.1136/jcp.37.1.59

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  19 in total

Review 1.  Iron overload--clinical and pathologic aspects.

Authors:  A Jacobs
Journal:  Semin Hematol       Date:  1977-01       Impact factor: 3.851

2.  Anemia in uremia.

Authors:  J F Desforges
Journal:  Arch Intern Med       Date:  1970-11

3.  Blood loss during maintenance hemodialysis.

Authors:  R E Longnecker; J A Goffinet; E D Hendler
Journal:  Trans Am Soc Artif Intern Organs       Date:  1974

4.  Hypersplenism in the uremic hemodialyzed patient: pathology and proposed pathophysiologic mechanisms.

Authors:  R S Neiman; M D Bischel; R J Lukes
Journal:  Am J Clin Pathol       Date:  1973-10       Impact factor: 2.493

5.  Characteristics of iron dextran utilization in man.

Authors:  P A Henderson; R S Hillman
Journal:  Blood       Date:  1969-09       Impact factor: 22.113

6.  Serum ferritin assay and iron status in chronic renal failure and haemodialysis.

Authors:  S Hussein; J Prieto; M O'Shea; A V Hoffbrand; R A Baillod; J F Moorhead
Journal:  Br Med J       Date:  1975-03-08

7.  Hemosiderosis secondary to chronic parenteral iron therapy in maintenance hemodialysis patients.

Authors:  T O Pitts; G L Barbour
Journal:  Nephron       Date:  1978       Impact factor: 2.847

8.  Iron induced increase in red cell size in haemodialysis patients.

Authors:  R Gokal; D J Weatherall; C Bunch
Journal:  Q J Med       Date:  1979-07

9.  Iron metabolism in haemodialysis patients. A study of the management of iron therapy and overload.

Authors:  R Gokal; P R Millard; D J Weatherall; S T Callender; J G Ledingham; D O Oliver
Journal:  Q J Med       Date:  1979-07

10.  Therapy of iron deficiency anemia in patients on maintenance dialysis.

Authors:  P A Parker; M W Izard; J F Maher
Journal:  Nephron       Date:  1979       Impact factor: 2.847
View more
  4 in total

1.  Hepatic iron in dialysed patients given intravenous iron dextran.

Authors:  L W Fleming; D Hopwood; A N Shepherd; W K Stewart
Journal:  J Clin Pathol       Date:  1990-02       Impact factor: 3.411

2.  Spleen size in chronic renal failure.

Authors:  M M Platts; E Anastassiades; S Sheriff; S Smith; D C Bartolo
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-24

3.  Iron biodistribution profile changes in the rat spleen after administration of high-fat diet or iron supplementation and the role of curcumin.

Authors:  Aziz Awaad; Hekmat Osman Abdel Aziz
Journal:  J Mol Histol       Date:  2021-05-28       Impact factor: 2.611

4.  Splenomegaly, hypersplenism and peripheral blood cytopaenias in patients with classical Anderson-Fabry disease.

Authors:  João Paulo Oliveira; Carmen Valbuena; António Baldaia Moreira; Elsa Fonseca; Carlos Soares; Elisa Leão Teles; Stephen Waldek
Journal:  Virchows Arch       Date:  2008-09-02       Impact factor: 4.535
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.